Download PDF
Pharmacopsychiatry 2005; 38(2): 87-94
DOI: 10.1055/s-2005-837808
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Impact of Experimentally Induced Serotonin Deficiency by Tryptophan Depletion on Saliva Cortisol Concentrations

K. Vielhaber1 , D. Riemann1 , B. Feige1 , A. Kuelz1 , C. Kirschbaum2 , U. Voderholzer1
  • 1Department of Psychiatry and Psychotherapy, University Hospital of Freiburg, Germany
  • 2Department of Psychology, University of Duesseldorf, Germany
Further Information

Publication History

Received: 24.9.2003 Revised: 20.1.2004

Accepted: 1.9.2004

Publication Date:
02 March 2005 (online)

Also available at
    Permissions and Reprints

Background: Tryptophan depletion (TD) has been shown to induce a transient mood-lowering effect in psychiatric patients and susceptible healthy subjects. We investigated the effects of TD on cortisol secretion in psychiatric patients and healthy subjects based on the hypothesis that the potential mood-lowering effects may be associated with increased activity of the hypothalamic-pituitary-adrenal axis, thus leading to a rise of cortisol secretion. Methods: After TD at 18.00 h, salivary cortisol was sampled in the evening and on the following morning. The first study was a randomized, placebo-controlled, crossover study in healthy subjects. Two further open trials in patients with obsessive-compulsive disorder (OCD) and primary insomnia compared the effects of TD on cortisol with baseline conditions. Results: In healthy subjects, TD significantly diminished cortisol the next morning compared with placebo. In OCD patients and primary insomniacs, cortisol the morning after TD was lowered compared with baseline. Evening cortisol was not affected by TD in any of the groups. Conclusions: Contrary to expectation, TD led to a comparable decrease of morning cortisol in all groups investigated. However, these findings are consistent with former studies analyzing the impact of antiserotonergic drugs on cortisol secretion. The results underline that the antiserotonergic effects caused by TD may influence cortisol secretion.

References

  • 1 Aperia B, Thorén M, Zettergren M, Wetterberg L. Plasma pattern of adrenocorticotropin and cortisol during electroconvulsive therapy in patients with major depressive illness.  Acta Psychiatr Scand. 1984;  70 361-369
    PubMedGoogle Scholar
  • 2 Asnis G M, Halbreich U, Rabinovich H, Ryan N D, Sachar E J, Nelson B. et al . The cortisol response to desipramine in endogenous depressives and normal controls: preliminary findings.  Psychiatry Res. 1985;  14 225-233
    CrossrefPubMedGoogle Scholar
  • 3 Attenburrow M J, Mitter P R, Whale R, Terao T, Cowen P J. Low-dose citalopram as a 5-HT neuroendocrine probe.  Psychopharmacology. 2001;  155 323-326
    CrossrefPubMedGoogle Scholar
  • 4 Barr L C, Heninger G R, Goodman W, Charney D S, Price L H. Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects.  Biol Psychiatry. 1997;  41 949-954
    CrossrefPubMedGoogle Scholar
  • 5 Bell C, Abrams J, Nutt D. Tryptophan depletion and its implications for psychiatry.  Br J Psychiatry. 2001;  178 399-405
    CrossrefPubMedGoogle Scholar
  • 6 Benkelfat C, Ellenbogen M, Dean P, Palmour R, Young S. Mood lowering effect of tryptophan depletion.  Arch Gen Psychiatry. 1994;  51 687-697
    PubMedGoogle Scholar
  • 7 Bjork J M, Dougherty D M, Moeller G, Swann A C. Differential behavioral effects of plasma tryptophan depletion and loading in aggressive and nonaggressive men.  Neuropsychopharmacology. 2000;  22 357-369
    CrossrefPubMedGoogle Scholar
  • 8 Booij L, Van der Does W, Benkelfat C, Bremner J D, Cowen P J, Fava M. et al . Predictors of mood response to acute tryptophan depletion. A reanalysis.  Neuropsychopharmacology. 2002;  27 852-861
    CrossrefPubMedGoogle Scholar
  • 9 Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.  Pharmacopsychiatry. 2003;  S3 230-234
    PubMedGoogle Scholar
  • 10 Büttner-Westphal H, Hand I. Yale-Brown Obsessive Compulsive Scale, Deutsche Übersetzung und Bearbeitung.  Verhaltenstherapie. 1991;  1 226-233
    PubMedGoogle Scholar
  • 11 Chihara K, Kato Y, Maeda K, Matsukura S, Imura H. Suppression by cyproheptadine of human growth hormone and cortisol secretion during sleep.  J Clin Invest. 1976;  57 1393-1402
    PubMedGoogle Scholar
  • 12 Cowen P J, Charig E M. Neuroendocrine responses to intravenous tryptophan in major depression.  Arch Gen Psychiatry. 1987;  44 958-966
    PubMedGoogle Scholar
  • 13 DeBattista C, Posener J A, Kalehzan B M, Schatzberg A F. Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study.  Am J Psychiatry. 2000;  157 1334-1337
    CrossrefPubMedGoogle Scholar
  • 14 Delgado P, Charney D, Price L, Aghajanian G, Landis H, Heninger G. Serotonin and the mechanism of antidepressant action.  Arch Gen Psychiatry. 1990;  47 411-418
    PubMedGoogle Scholar
  • 15 Delgado P, Price S, Miller H, Salomon R, Aghajanian G, Heninger F. et al . Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug free depressed patients.  Arch Gen Psychiatry. 1994;  51 865-874
    PubMedGoogle Scholar
  • 16 Delgado P, Moreno F. Antidepressants and the brain.  Int Clin Psychopharmacol.. 1999;  14 suppl. 1 9-16
    PubMedGoogle Scholar
  • 17 Delgado P L, Moreno F A. Role of norepinephrine in depression.  J Clin Psychiatry. 2000;  61 suppl. 1 5-12
    Google Scholar
  • 18 Ellenbogen M A, Young S N, Dean P, Palmour R M, Benkelfat C. Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability.  Neuropsychopharmacology. 1996;  15 465-474
    CrossrefPubMedGoogle Scholar
  • 19 Feuchtl A, Bagli M, Stephan R, Frahnert C, Kölsch H, Kühn K U. et al . Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile.  Pharmacopsychiatry. 2004;  4 180-188
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Franklin M, Cowen P J. Effect of a low tryptophan diet on the prolactin responses to the 5-HT2A agonist DOI in the rat.  Pharmacopsychiatry. 2001;  34 147-149
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Gessa G L, Biggio G, Fadda F, Corsini G V, Tagliamonte A. Effect of oral administration of tryptophan-free amino acid mixtures on serum tryptophan, brain tryptophan and serotonin metabolism.  J Neurochem. 1974;  22 869-870
    PubMedGoogle Scholar
  • 22 Goddard A W, Charney D S, Germine M, Woods S W, Heninger G R, Krystal J H. et al . Effects of tryptophan depletion on responses to yohimbine in healthy subjects.  Biological Psychiatry. 1995;  38 74-85
    CrossrefPubMedGoogle Scholar
  • 23 Golden R N, Ekstrom D, Brown T M, Ruegg R, Dwight L E, Haggerty JJ J r. et al . Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects.  Am J Psychiatry. 1992;  149 1168-1175
    PubMedGoogle Scholar
  • 24 Goodman W K, Price L H, Rasmussen S A, Mazure C, Fleischmann R L, Hill C L. et al . The Yale-Brown Obsessive Compulsive Scale: I. Development, use and reliability.  Arch Gen Psychiatry. 1989a;  46 1012-1016
    PubMedGoogle Scholar
  • 25 Goodman W K, Price L H, Rasmussen S A, Mazure C, Delgado P, Heninger G R. et al . The Yale-Brown Obsessive Compulsive Scale: II. Validity.  Arch Gen Psychiatry. 1989b;  46 1006-1011
    PubMedGoogle Scholar
  • 26 Goodwin G M, Muir W J, Seckl J R, Bennie J, Carroll S, Dick H. et al . The effects of cortisol infusion upon hormone secretion from the anterior pituitary and subjective mood in depressive illness and in controls.  J Affective Disord. 1992;  26 73-83
    CrossrefPubMedGoogle Scholar
  • 27 Harmer C J, Bhagwagar Z, Shelley N, Cowen P J. Contrasting effects of citalopram and reboxetine on waking salivary cortisol.  Psychopharmacology. 2003;  167 112-114
    PubMedGoogle Scholar
  • 28 Heim C, Ehlert U, Hellhammer D H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders.  Psychoneuroendocrinology. 2000;  25 1-35
    PubMedGoogle Scholar
  • 29 Heninger G R, Delgado P L, Charney D S. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans.  Pharmacopsychiatry. 1996;  29 2-11
    PubMedGoogle Scholar
  • 30 Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation.  Endocrine Rev. 1996;  17 187-205
    CrossrefPubMedGoogle Scholar
  • 31 Huwig-Poppe C, Voderholzer U, Backhaus J, Riemann D, König A, Hohagen F. The tryptophan depletion test. Impact on sleep in healthy subjects and patients with obsessive-compulsive disorder.  Advan Exp Med Biol. 1999;  467 35-42
    PubMedGoogle Scholar
  • 32 Kirschbaum C, Hellhammer D H. Salivary cortisol in psychoneuroendocrine research: recent developments and applications.  Psychoneuroendocrinol. 1994;  19 313-333
    CrossrefPubMedGoogle Scholar
  • 33 Kling M A, Geracioti T D, Licinio J, Michelson D, Oldfield E H, Gold P W. Effects of electroconvulsive therapy on the CRH-ACTH-Cortisol system in melancholic depression: preliminary findings.  Psychopharmacol Bulletin. 1994;  30 489-494
    PubMedGoogle Scholar
  • 34 Kojima H, Terao T, Iwakawa M, Soya A, Inoue N, Shiraishi Y. et al . Paroxetine as a 5-HT neuroendocrine probe.  Psychopharmacology. 2003;  167 97-102
    PubMedGoogle Scholar
  • 35 Leproult R, Copinschi G, Buxton O, van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening.  Sleep. 1997;  20 865-870
    PubMedGoogle Scholar
  • 36 Matza L S, Revicki D A, Davidson J R, Stewart J W. Depression with atypical features in the National Comorbidity Survey: classification, description and consequences.  Arch Gen Psychiatry. 2003;  60 817-826
    CrossrefPubMedGoogle Scholar
  • 37 Moja E A, Cipolla P, Castoldi D, Tofanetti O. Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats.  Life Sci. 1989;  44 971-976
    CrossrefPubMedGoogle Scholar
  • 38 Moreno F A, Gelenberg A J, Heninger G R, Potter R L, McKnight K M, Allen J. et al . Tryptophan depletion and depressive vulnerability.  Biol Psychiatry. 1999;  46 498-505
    CrossrefPubMedGoogle Scholar
  • 39 Murck H. Atypical depression spectrum disorder - neurobiology and treatment.  Acta Neuropsychiatrica. 2003;  15 227-241
    CrossrefPubMedGoogle Scholar
  • 40 Neumeister A, Praschak-Rieder N, Heßelmann B, Vitouch O, Rauh M, Barocka A. et al . Effects of tryptophan depletion in drug-free depressed patients who responded to total sleep deprivation.  Arch Gen Psychiatry. 1998;  55 167-172
    PubMedGoogle Scholar
  • 41 Parker K J, Schatzberg A F, Lyons D M. Neuroendocrine aspects of hypercortisolism in major depression.  Horm Behav. 2003;  43 60-66
    CrossrefPubMedGoogle Scholar
  • 42 Pigott T A, L’Heureux F, Dubbert B, Bernstein S, Murphy D L. Obsessive compulsive disorder: comorbid conditions.  J Clin Psychiatry. 1994;  55 suppl 15 - 27, discussion 28 - 32
    PubMedGoogle Scholar
  • 43 Plonk J, Feldman J. Modification of adrenal function by the anti-serotonin agent cyproheptadine.  J Clin Endocrinol Metab. 1976;  42 291-295
    PubMedGoogle Scholar
  • 44 Porter R J, Marshall E F, O’Brien J T. Effects of rapid tryptophan depletion on salivary and plasma cortisol in Alzheimer’s disease and the healthy elderly.  Journal of Psychopharmacology. 2002;  16 73-78
    PubMedGoogle Scholar
  • 45 Price L H, Malison R T, McDougle C J, McCance-Katz E F, Owen K R, Heninger G R. Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP).  Neuropsychopharmacology. 1997;  17 342-350
    CrossrefPubMedGoogle Scholar
  • 46 Price L H, Malison R T, McDougle C J, Pelton G H, Heninger G R. The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion.  Biological Psychiatry. 1998;  43 339-347
    CrossrefPubMedGoogle Scholar
  • 47 Riedel W J, Klaassen T, Schmitt J A. Tryptophan, mood, and cognitive function.  Brain Behav Immun. 2002;  16 581-589
    CrossrefPubMedGoogle Scholar
  • 48 Riemann D, Hornyak M, Koch S, Hohagen F, Voderholzer U. The tryptophan-depletion test: Impact on sleep in primary insomnia - a pilot study.  Psychiat Res. 2002;  109 129-135
    CrossrefPubMedGoogle Scholar
  • 49 Schüle C, Baghai T, Ferrera A, Laakmann G. Neuroendocrine effects of Hypericum extract WS 5570 in 12 healthy male volunteers.  Pharmacopsychiatry. 2001;  34 suppl. 1 127-133
    Article in Thieme ConnectPubMedGoogle Scholar
  • 50 Sobczak S, Honig A, Nicolson N A, Riedel W J. Effects of acute tryptophan depletion on mood and cortisol release in first-degree relatives of type I and type II bipolar patients and healthy matched controls.  Neuropsychopharmacology. 2002;  27 834-842
    CrossrefPubMedGoogle Scholar
  • 51 Spiegel K, Leproult R, Cauter van E. Impact of sleep debt on metabolic and endocrine function.  Lancet. 1999;  354 1435-1439
    CrossrefPubMedGoogle Scholar
  • 52 Spitzer R L, Williams J B, Gibbons M. The structured clinical interview for DSM-III-R. Biometrics Research Department. New York State Psychiatric Institute New York; 1984
    Google Scholar
  • 53 Ströhle A, Holsboer F. Stress Responsive Neurohormones in Depression and Anxiety.  Pharmacopsychiatry. 2003;  S3 207-214
    PubMedGoogle Scholar
  • 54 Tsigos C, Chrousos G P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress.  J Psychosom Res. 2002;  53 865-871
    CrossrefPubMedGoogle Scholar
  • 55 Voderholzer U, Hohagen F, Klein T, Jungnickel J, Kirschbaum C, Berger M. et al . Impact of Sleep Deprivation and Subsequent Recovery Sleep on Cortisol in Unmedicated Depressed Patients.  Am J Psychiatry. 2004;  161 1404-1410
    CrossrefPubMedGoogle Scholar
  • 56 Voderholzer U, Hornyak M, Thiel B, Huwig-Poppe C, Kiemen A, König A. et al . Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects.  Neuropsychopharmacology. 1998;  18 112-124
    CrossrefPubMedGoogle Scholar
  • 57 Weitzman E D, Zimmerman J C, Czeisler C A, Ronda J. Cortisol secretion is inhibited during sleep in normal man.  J Clin Endocrinol Metab. 1983;  56 352-358
    PubMedGoogle Scholar
  • 58 Wittchen H U, Zaudig M, Schramm E, Spengler P, Mombour B, Kleig J. et al .Strukturiertes klinisches Interview für DSM-III-R (SKID-P). Beltz-Test Weinheim; 1988
    Google Scholar
  • 59 Wüst S, Federenko I, Hellhammer D H, Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening.  Psychoneuroendocrinology. 2000;  25 707-720
    PubMedGoogle Scholar
  • 60 Young S N, Smith S E, Pihl R O, Ervin F R. Tryptophan depletion causes a rapid lowering of mood in normal males.  Psychopharmacology. 1985;  87 173-177
    CrossrefPubMedGoogle Scholar
  • 61 Zerssen von D. Clinical Self-Rating Scales (CSRS) of the Munich Psychiatry Information System (PSYCHIS München). In Sartorius N, Ban TA, editors Assessment of Depression. Berlin Heidelberg New York Tokyo; Springer 1986: pp 270-303
    Google Scholar

Ulrich Voderholzer, MD

Department of Psychiatry and Psychotherapy

Klinikum of the Albert-Ludwigs-University

Hauptstrasse 5

79104 Freiburg

Germany

Phone: +49-761-270-6603 (-6501)

Fax: +49-761-270-6667

Email: Ulrich_Voderholzer@psyallg.ukl.uni-freiburg.de

      >